Viatris Inc is recalling 16,385 bottles of Cardura XL (doxazosin) extended release tablets, a prescription medication used to treat high blood pressure and symptoms of an enlarged prostate. The recall was initiated because the tablets failed to meet required specifications for impurities and degradation. This means the medication may contain unintended substances that could compromise its quality or safety. To date, no injuries or incidents related to this issue have been reported.
Failed impurity and degradation specifications indicate that the chemical composition of the medication has changed or contains unintended byproducts. This poses a risk as it may reduce the effectiveness of the drug or expose the patient to unexpected substances, although the specific health impact depends on the nature of the impurity.
You have 2 options:
Distributed by Roerig Division of Pfizer Inc.
Distributed by Roerig Division of Pfizer Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.